Silence Therapeutics (SLN) Cash & Equivalents (2018 - 2026)
Silence Therapeutics (SLN) reported Cash & Equivalents of $72.05 million for the quarter ended Jun 30, 2026, up 72.6% from $41.74 million a year earlier.
Powered by 
Analysis
Silence Therapeutics (SLN) Cash & Equivalents (2018 - 2026) Analysis & Trends
As of Dec 31, 2025, Silence Therapeutics posted Cash & Equivalents of $11.28 million, down 90.7% from the prior year.
- Cash & Equivalents has a five-year compound annual growth rate of -20.4% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Equivalents came in at $121.33 million in the year ended Dec 31, 2024 (+76.4%), $68.79 million in the year ended Dec 31, 2023 (+1.4%), $67.84 million in the year ended Dec 31, 2022 (-32.9%) and $101.18 million in the year ended Dec 31, 2021 (+187.0%).
- Five-year quarterly Cash & Equivalents spans a low of $5.66 million in the quarter ended Mar 31, 2026 and a high of $121.33 million in the quarter ended Dec 31, 2024.
- Year over year, Cash & Equivalents gained in two of the last four quarters, with an average decline of 7.1%.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $5.66 million (quarter ended Mar 31, 2026), $11.28 million (quarter ended Dec 31, 2025) and $82.03 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Silence Therapeutics | 502.70 Mn | 430.60 Mn | - | 72.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.05 Mn |
| Mar 31, 2026 | 5.66 Mn |
| Dec 31, 2025 | 11.28 Mn |
| Sep 30, 2025 | 82.03 Mn |
| Jun 30, 2025 | 41.74 Mn |
| Mar 31, 2025 | 64.89 Mn |
| Dec 31, 2024 | 121.33 Mn |
| Dec 31, 2023 | 67.06 Mn |
| Dec 31, 2022 | 64.30 Mn |
| Dec 31, 2021 | 99.13 Mn |
| Dec 31, 2020 | 36.25 Mn |
| Dec 31, 2019 | 17.38 Mn |
| Dec 31, 2018 | 27.66 Mn |
API Access
Silence Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();